Lista publicaţiilor: Vaillant Andrew - 4

2023 - 2

Noi tendințe de tratament în hepatita virală B+D

Cojuhari Lilia Boris, Plăcintă Gheorghe Petru, Pântea Victor Efim, Cebotarescu Valentin Titu, Iarovoi Liviu Petru, Vaillant Andrew , Bazinet Michel

1 Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, 2 Replicor, Montreal, QC

Sănătate Publică, Economie şi Management în Medicină

Nr. 3(96_S) / 2023 / ISSN 1729-8687 / ISSNe 2587-3873

Disponibil online 5 January, 2024

-----------------------------------------------------------------------------------------------------------------------------------

Eficacitatea tratamentului cu polimeri ai acizilor nucleici în hepatita virală b cronică aghbe negativă

Cebotarescu Valentin Titu, Plăcintă Gheorghe Petru, Pântea Victor Efim, Cojuhari Lilia Boris, Iarovoi Liviu Petru, Smeşnoi Valentina Isidor, Vaillant Andrew , Bazinet Michel

1 Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, 2 Spitalul Clinic Republican de Boli Infecţioase „Toma Ciorbă“, 3 Replicor, Montreal, QC

Sănătate Publică, Economie şi Management în Medicină

Nr. 3(96_S) / 2023 / ISSN 1729-8687 / ISSNe 2587-3873

Disponibil online 4 January, 2024

-----------------------------------------------------------------------------------------------------------------------------------

2020 - 1

Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg

Shekhtman Louis M. , Cotler Scott J. , Hershkovich Leeor , Uprichard Susan L. , Bazinet Michel , Pântea Victor Efim, Cebotarescu Valentin Titu, Cojuhari Lilia Boris, Jimbei Pavlina, Krawczyk Adalbert, Dittmer Ulf , Vaillant Andrew , Dahari Harel

1 Northeastern University, 2 Loyola University Medical Center, Maywood, 3 Replicor, Montreal, QC, 4 ”Nicolae Testemițanu” State University of Medicine and Pharmacy, 5 Toma Ciorba Clinical Hospital of Infectious Diseases, 6 Duisburg - Essen University

Scientific Reports

Nr. 1(10) / 2020 / ISSN 2045-2322

Disponibil online 1 June, 2020

-----------------------------------------------------------------------------------------------------------------------------------

2017 - 1

Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial

Bazinet Michel , Pântea Victor Efim, Cebotarescu Valentin Titu, Cojuhari Lilia Boris, Jimbei Pavlina, Albrecht Jeff A, Schmid Peter, Le Gal Frédéric, Gordien Emmanuel, Krawczyk Adalbert, Mijocevic Hrvoje, Karimzadeh Hadi, Roggendorf Michael, Vaillant Andrew

1 Replicor, Montreal, QC, 2 ”Nicolae Testemițanu” State University of Medicine and Pharmacy, 3 Toma Ciorba Clinical Hospital of Infectious Diseases, 4 National Genetics Institute, 5 Université Sorbonne Nouvelle - Paris 3, 6 Duisburg - Essen University, 7 Technical University Munich

The Lancet Gastroenterology and Hepatology

Nr. / 2017 / ISSN 2468-1253

Disponibil online 11 December, 2017

-----------------------------------------------------------------------------------------------------------------------------------

10203040501005001000